Intellectual Property India Publishes Patent Application for 'Process For The Production Of 5-(4-((2 S,5 S)-5-(4-Chlorobenzyl)-2- Methylmorpholino)Piperidin-1-Yl)-1 H-1,2,4-Triazol-3-Amine' Filed by Molecure Spolka Akcyjna

MUMBAI, India, March 14 -- Intellectual Property India has published a patent application (202618014523 A) filed by Molecure Spolka Akcyjna, Warszawa, Poland, on Feb. 10, for 'process for the production of 5-(4-((2 s,5 s)-5-(4-chlorobenzyl)-2- methylmorpholino)piperidin-1-yl)-1 h-1,2,4-triazol-3-amine.'

Inventor(s) include Witkowski, Grzegorz; Magdycz, Marta; Tyszkiewicz, Magdalena; Zakrzewski, Marcin; and Pikul, Stanislaw.

The application for the patent was published on March 13, under issue no. 11/2026.

According to the abstract released by the Intellectual Property India: "The present invention relates to a process for the synthesis of 5-(4-((2S,5S)-5-(4-chlorobenzyl)- 2-methylmorpholino)piperidin-1-yl)-1H-1,2,4-triazol-3-amine in two hydrated crystalline forms and in one anhydrous crystalline form. The present invention further relates to methyl (Z)-4-((2S,5S)-5-(4-chlorobenzyl)-2-methylmorpholino)-N-cyanopiperidine-1-carbimidothioate which is an intermediate in this process."

The patent application was internationally filed on Sept. 25, 2020, under International application No.PCT/IB2020/058984.

Disclaimer: Curated by HT Syndication.